Filters
Other countries
Results: 1 to 14 of 14
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
TAF1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Neurodevelopmental Disorders Panel Invitae United States | 404 | 241 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Invitae United States | 638 | 419 |
|
X-linked Intellectual Disability via the TAF1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Cornelia de Lange Syndrome and Cornelia de Lange Syndrome-Related Disorders Panel PreventionGenetics, part of Exact Sciences United States | 43 | 42 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 328 | 300 |
|
Invitae Cornelia de Lange Syndrome and Related Disorders Panel Invitae United States | 44 | 31 |
|
X-Linked Intellectual Disability Panel PreventionGenetics, part of Exact Sciences United States | 191 | 141 |
|
X-linked intellectual disability panel. 99-gene NGS panel. Genologica Medica Spain | 143 | 99 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Mental retardation, X-linked syndromic: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 33 | 31 |
|
Asper Biogene Asper Biogene LLC Estonia | 42 | 30 |
|
Results: 1 to 14 of 14
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.